182 related articles for article (PubMed ID: 26961112)
1. Control Status of Atherosclerotic Cardiovascular Risk Factors Among Japanese High-Risk Subjects:Analyses of a Japanese Health Check Database from 2008 to 2011.
Hasegawa K; Tsukamoto K; Kunimi M; Asahi K; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Fujimoto S; Narita I; Konta T; Kondo M; Kimura K; Ohashi Y; Watanabe T
J Atheroscler Thromb; 2016 Aug; 23(8):991-1003. PubMed ID: 26961112
[TBL] [Abstract][Full Text] [Related]
2. Association between Prescription and Control Status of Dyslipidemia and Hypertension among Japanese Patients with Diabetes.
Sakamoto M; Edo N; Takahashi S; Okamura E; Uno K; Morita K; Ishikawa T; Asahi K; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Fujimoto S; Narita I; Konta T; Kondo M; Kimura K; Ohashi Y; Watanabe T; Tsukamoto K
J Atheroscler Thromb; 2019 Sep; 26(9):805-820. PubMed ID: 30726791
[TBL] [Abstract][Full Text] [Related]
3. Pitavastatin: clinical effects from the LIVES Study.
Teramoto T
Atheroscler Suppl; 2011 Nov; 12(3):285-8. PubMed ID: 22152283
[TBL] [Abstract][Full Text] [Related]
4. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
5. A retrospective, cross-sectional study of real-world values of cardiovascular risk factors using a healthcare database in Japan.
Shima D; Ii Y; Yamamoto Y; Nagayasu S; Ikeda Y; Fujimoto Y
BMC Cardiovasc Disord; 2014 Sep; 14():120. PubMed ID: 25231128
[TBL] [Abstract][Full Text] [Related]
6. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
7. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
[TBL] [Abstract][Full Text] [Related]
8. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M;
Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
10. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial.
AIM-HIGH Investigators
Am Heart J; 2011 Mar; 161(3):538-43. PubMed ID: 21392609
[TBL] [Abstract][Full Text] [Related]
11. N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.
Ide K; Koshizaka M; Tokuyama H; Tokuyama T; Ishikawa T; Maezawa Y; Takemoto M; Yokote K
Lipids Health Dis; 2018 Mar; 17(1):51. PubMed ID: 29544483
[TBL] [Abstract][Full Text] [Related]
12. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.
Mark L; Vallejo-Vaz AJ; Reiber I; Paragh G; Kondapally Seshasai SR; Ray KK
Atherosclerosis; 2015 Jul; 241(1):62-8. PubMed ID: 25966441
[TBL] [Abstract][Full Text] [Related]
13. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
14. Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).
Spinler SA; Cziraky MJ; Willey VJ; Tang F; Maddox TM; Thomas T; Dueñas GG; Virani SS;
Am J Cardiol; 2015 Aug; 116(4):547-53. PubMed ID: 26089010
[TBL] [Abstract][Full Text] [Related]
15. HDL-C: role as a risk modifier.
Barter P
Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
[TBL] [Abstract][Full Text] [Related]
16. Association between hemoglobin and diabetes in relation to the triglycerides-to-high-density lipoprotein cholesterol (TG-HDL) ratio in Japanese individuals: the Nagasaki Islands Study.
Shimizu Y; Nakazato M; Sekita T; Koyamatsu J; Kadota K; Yamasaki H; Goto H; Takamura N; Aoyagi K; Maeda T
Intern Med; 2014; 53(8):837-43. PubMed ID: 24739603
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study.
Wong ND; Zhao Y; Patel R; Patao C; Malik S; Bertoni AG; Correa A; Folsom AR; Kachroo S; Mukherjee J; Taylor H; Selvin E
Diabetes Care; 2016 May; 39(5):668-76. PubMed ID: 27208374
[TBL] [Abstract][Full Text] [Related]
18. Knowledge of HbA1c and LDL-C treatment goals, subjective level of disease-related information and information needs in patients with atherosclerotic cardiovascular disease.
Brockmeyer M; Wies E; Joerges J; Sommer J; Borgmann SO; Chernyak N; Lin Y; Parco C; Schulze V; Heinen Y; Kelm M; Icks A; Perings S; Wolff G
Clin Cardiol; 2023 Feb; 46(2):223-231. PubMed ID: 36448416
[TBL] [Abstract][Full Text] [Related]
19. Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.
Lewin AJ; Kipnes MS; Meneghini LF; Plotkin DJ; Perevozskaya IT; Shah S; Maccubbin DL; Mitchel YB; Tobert JA;
Clin Ther; 2004 Mar; 26(3):379-89. PubMed ID: 15110130
[TBL] [Abstract][Full Text] [Related]
20. Low HDL cholesterol but not high LDL cholesterol is independently associated with subclinical coronary atherosclerosis in healthy octogenarians.
Freitas WM; Quaglia LA; Santos SN; de Paula RC; Santos RD; Blaha M; Rivera JJ; Cury R; Blumenthal R; Nadruz-Junior W; Agatston A; Figueiredo VN; Nasir K; Sposito AC;
Aging Clin Exp Res; 2015 Feb; 27(1):61-7. PubMed ID: 24906678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
